ACTIVE

Viatris GX

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

407,1 k €

+2.9% YoY

Equity

27,9 M €

+1.5% YoY

What does Viatris GX do?

Viatris GX is a Private limited company incorporated in 2006. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Hoeilaart.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0885.805.780

Incorporation

20/12/2006

Legal form

Private limited company

Registered office

Terhulpsesteenweg 6A
1560 Hoeilaart · FlandreSee on map

Contributed capital

24 576 264,30 €

Latest accounts

31/12/2025

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport

Joint committees (2)

Signals

ProfitableSolid equityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 15 financial years

	2025		2024		2023		2022		2020		2019		2018		2017		2016		2015		2014		2013		2012		2009		2008
Income statement
Revenue	–		–		0 €	-100%	12,9 k €	-100.0%	28,2 M €	+7.8%	26,2 M €	+26.5%	20,7 M €	+3.9%	19,9 M €	+1.3%	19,7 M €	-4.2%	20,5 M €	-11.7%	23,3 M €	-3.6%	24,1 M €	-24.1%	31,8 M €	-20.0%	39,7 M €	-4.5%	41,6 M €
EBITDA	686,2 k €	+15.1%	596 k €	-34.5%	909,7 k €	+126%	402,4 k €	-52.3%	844,5 k €	-64.6%	2,4 M €	+176%	-3,1 M €	+13.1%	-3,6 M €	+41.9%	-6,2 M €	+30.0%	-8,8 M €	-68.4%	-5,2 M €	-56.1%	-3,4 M €	-1524%	236 k €	-94.6%	4,4 M €	+14.0%	3,8 M €
Operating result	665,7 k €	+16.6%	570,8 k €	-35.0%	878,6 k €	+138%	369,8 k €	-82.4%	2,1 M €	+6.3%	2 M €	+172%	-2,7 M €	+32.6%	-4 M €	+44.2%	-7,2 M €	+21.9%	-9,3 M €	-4.6%	-8,9 M €	-21.0%	-7,3 M €	-282%	-1,9 M €	-135%	5,5 M €	+47.0%	3,7 M €
Net result	407,1 k €	+2.9%	395,4 k €	-30.9%	571,9 k €	+232%	172,1 k €	-87.3%	1,4 M €	-18.3%	1,7 M €	+156%	-3 M €	+30.0%	-4,2 M €	+73.7%	-16 M €	-91.8%	-8,4 M €	+34.6%	-12,8 M €	-18.2%	-10,8 M €	-93.6%	-5,6 M €	-264%	3,4 M €	+52.8%	2,2 M €
Balance sheet
Equity	27,9 M €	+1.5%	27,5 M €	+1.5%	27,1 M €	+2.2%	26,6 M €	+7.6%	24,7 M €	+5.8%	23,3 M €	+7.7%	21,7 M €	-12.0%	24,6 M €	-14.6%	28,9 M €	+153%	11,4 M €	-22.8%	14,8 M €	+264%	4,1 M €	-45.0%	7,4 M €	-43.9%	13,1 M €	+35.1%	9,7 M €
Total assets	31,1 M €	-0.6%	31,3 M €	-0.1%	31,3 M €	-23.4%	40,9 M €	-25.9%	55,2 M €	+6.9%	51,6 M €	+2.8%	50,2 M €	+7.8%	46,6 M €	+11.0%	42 M €	-18.5%	51,5 M €	-13.0%	59,2 M €	-3.0%	61 M €	+1.1%	60,4 M €	+227%	18,5 M €	-2.0%	18,9 M €
Cash	–		–		–		1,4 M €	+69.2%	848,3 k €	+147%	343,6 k €	-66.0%	1 M €	+567%	151,5 k €	-87.1%	1,2 M €	-56.1%	2,7 M €	-39.7%	4,4 M €	+86.4%	2,4 M €	+61.5%	1,5 M €	-22.0%	1,9 M €	-36.8%	3 M €
Debts	3,2 M €	-15.7%	3,8 M €	-10.3%	4,2 M €	-70.8%	14,3 M €	-52.9%	30,5 M €	+7.8%	28,3 M €	-1.0%	28,5 M €	+29.9%	22 M €	+67.2%	13,1 M €	-67.2%	40,1 M €	-9.7%	44,4 M €	-14.6%	52 M €	+1.3%	51,3 M €	+864%	5,3 M €	-41.6%	9,1 M €
Other
Workforce	–		–		–		0,0 ETP	-100%	72,8 ETP	-1.2%	73,7 ETP	+16.2%	63,4 ETP	+8.6%	58,4 ETP	-13.5%	67,5 ETP	-12.7%	77,3 ETP	+2.2%	75,6 ETP	+8.3%	69,8 ETP	-11.8%	79,1 ETP	+25.0%	63,3 ETP	-1.2%	64,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 29 ended

Active mandates

Arun NARAYAN

Director · since 26 novembre 2025

Active

Tomasz BUCZEK

Director · since 25 juin 2025

Active

Ended mandates

Matthew Salzmann

Director · since 01 mars 2024

Ended

Luis Birbuet

Director · since 01 février 2021

Ended

Vincent Verschraegen

Director · since 18 décembre 2018

Ended

Vincent Verschraegen

Manager · since 18 décembre 2018

Ended

At this address

Other companies at this address

Company	CBE no.
AKTUAPHARMA● Active	0463.582.004
Upjohn● Active	0552.558.025
Viatris Healthcare● Active	0403.048.064
Viatris International Supply Point● Active	0463.648.419

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	07/07/2026	27/06/2025	27/06/2024	12/07/2023	11/10/2022	13/07/2021
General meeting	18/06/2026	19/06/2025	20/06/2024	28/06/2023	07/10/2022	17/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	18/06/2026	07/07/2026	Dutch	PDF
Full model	31/12/2024	19/06/2025	27/06/2025	Dutch	PDF
Full model	31/12/2023	20/06/2024	27/06/2024	Dutch	PDF
Full model	31/12/2022	28/06/2023	12/07/2023	Dutch	PDF
Full model	31/12/2021	07/10/2022	11/10/2022	Dutch	PDF
Full model	31/12/2020	17/06/2021	13/07/2021	Dutch	PDF
Full model	31/12/2019	18/06/2020	09/07/2020	Dutch	PDF
Full model	31/12/2018	20/06/2019	09/07/2019	Dutch	PDF
Full model	31/12/2017	31/08/2018	06/09/2018	Dutch	PDF
Full model	31/12/2016	30/08/2017	31/08/2017	Dutch	PDF
Full model	31/12/2015	16/06/2016	07/07/2016	Dutch	PDF
Full model	31/12/2014	18/06/2015	19/06/2015	Dutch	PDF
Full model	31/12/2013	19/06/2014	20/06/2014	Dutch	PDF
Full model	31/12/2012	20/06/2013	25/06/2013	Dutch	PDF
Full model	31/12/2011	27/04/2012	09/05/2012	Dutch	PDF
Full model	31/12/2010	16/09/2011	10/10/2011	Dutch	PDF
Full model	31/12/2009	20/07/2010	29/07/2010	Dutch	PDF
Full model	31/12/2008	12/03/2009	11/05/2009	Dutch	PDF
Full model	31/12/2007	20/03/2008	23/06/2008	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 29 ended

Active mandates

Arun NARAYAN

Director · since 26 novembre 2025

Active

Tomasz BUCZEK

Director · since 25 juin 2025

Active

Ended mandates

Matthew Salzmann

Director · since 01 mars 2024

Ended

Luis Birbuet

Director · since 01 février 2021

Ended

Vincent Verschraegen

Director · since 18 décembre 2018

Ended

Vincent Verschraegen

Manager · since 18 décembre 2018

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other02/07/2026
—
PDF
Mandates10/12/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/07/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates21/03/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/07/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/01/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/05/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/07/2020
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025407,1 k €↑
26/11/2025
nominationArun Narayan — bestuurder
25/06/2025
nominationTomasz Buczek — bestuurder
2024
Annual accounts 2024395,4 k €↓
01/03/2024
nominationMatthew Salzmann — bestuurder
2023
Annual accounts 2023571,9 k €↑
28/06/2023
reconductionDeloitte Bedrijfsrevisoren BV — commissaris
2022
Annual accounts 2022172,1 k €↓
2022
Name changeViatris GX BV
2020
Annual accounts 20201,4 M €↓
2019
Annual accounts 20191,7 M €↑
2018
Annual accounts 2018-3 M €↑
2017
Annual accounts 2017-4,2 M €↑
2016
Annual accounts 2016-16 M €↓
2015
Annual accounts 2015-8,4 M €↑
2014
Annual accounts 2014-12,8 M €↓
2013
Annual accounts 2013-10,8 M €↓
2012
Annual accounts 2012-5,6 M €↓
2009
Annual accounts 20093,4 M €↑
2008
Annual accounts 20082,2 M €
2008
Name changeMYLAN
20/12/2006
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Viatris GX

Overview

What does Viatris GX do?

Trend over 15 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline